Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
Prostate Cancer and Prostatic Diseases|October 11, 2025
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancerXiaolei Shi, Jarey H Wang, Brian F Chapin, et al.
Oncotarget|November 28, 2018
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitutionJoshua N Kellner, Eveline M Delemarre, Eric Yvon, et al.
Scientific Reports|June 18, 2020
Assessment of Luminal and Basal Phenotypes in Bladder CancerCharles C Guo, Jolanta Bondaruk, Hui Yao, et al.
BJU International|April 14, 2023
Definitive local therapy for T4 prostate cancer associated with improved local control and survivalLauren M Andring, Ibrahim Abu-Gheida, Tharakeswara Bathala, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samplesShuai Guo, Xiaoqian Liu, Xuesen Cheng, et al.
Cancers|December 23, 2023
Evaluation of the Aggressive-Variant Prostate Cancer Molecular Signature in Clinical Laboratory Improvement Amendments (CLIA) EnvironmentsPaul V Viscuse, Rebecca S Slack-Tidwell, Miao Zhang, et al.
Urology|May 10, 2025
GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical TrialsAndrew Fang, Daniel E Frigo, Andrew Hahn, et al.
The Lancet. Oncology|December 3, 2014
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trialKarim Fizazi, Lance Pagliaro, Agnes Laplanche, et al.
Oncogene|September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelEstefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
European Urology|December 6, 2020
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional TherapiesWeranja Ranasinghe, Daniel D Shapiro, Hyunsoo Hwang, et al.
Pageof 20